Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516440 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
EnterprisewideAdd to Basket
Site LicenseAdd to Basket
Live Chat Live Help Software for Website

U.S. Carotid and Intracranial Vascular Devices Markets

Frost & Sullivan, May 2006


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

This Frost & Sullivan research service entitled U.S. Carotid and Intracranial Devices Market provides an overview of the trends and technologies that have shaped market revenue, market share, and implantation rates in the individual segments of the market. In this research, Frost & Sullivans expert analysts thoroughly examine the following markets: Carotid Stents, Neurovascular Stents, and Embolic Devices.

Market Sector

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis:

- Cardiovascular Devices
- Stents
Technologies
The following technologies are covered in this research:

- Self Expanding Stents
- Bioadsorbable
- Rapid Exchange
- Microcoils
- Liquid Embolics
Market Overview
Advances in Imaging and Screening Provide Advanced Disease Warning, Spurring Usage of Preventative Therapeutic Options
Significant advances in non invasively imaging the carotid artery and cerebral neurovasculature are allowing for doctors to identify potential stroke victims sooner than ever. Stents and embolic procedures are most effective as preventative measures, as opposed to working within the narrow and critical time frame afforded after a stroke. CT scans, MRI, angiography, ultrasound, and single-photon emission computed tomography (SPRCT) are among the myriad of novel approaches being explored for mapping out disease states and treatment options. CT scans are in most cases 95 percent effective in diagnosing potential occlusions or aneurysm sites. They have short acquisition times, and can provide highly detailed morphological information. MRI systems are capable of providing information on flow patterns through phase-contrast techniques, whereby a markedly slow pattern might be the early stages of a developing occlusion. A Doppler ultrasound is similarly capable of identifying blood flow speed through non-invasively methodologies, and is capable of acquiring information in real time without the risk of radiation. The Doppler system though performs with less resolution than a MRI. The most advancements have occurred in angiography methodologies that now allow for detection and characterization of occlusion or rupture sites in acute hospital settings. Techniques such as digital subtraction angiography allow for identification of specific size and morphology. Angiography and catheter based imaging has received a significant boost due refinement of device size and ease of maneuverability. This driver will have a high impact in the near and long term future of the market.
The preventative stroke treatment market of the medical device industry is entering a new era of therapeutic treatment options. Refinements of carotid and neurovascular stent technology, along with microcoil and liquid embolic devices have empowered surgeons with new weapons in the battle against cerebrovascular diseases. In an industry mostly constrained due to reimbursement and lack of adequately trained providers , the upcoming decade should see the landscape of stroke prevention significantly altered. The advent of new more durable and pliable stent material along with the proliferation of self expanding stents are reshaping the future of the carotid and neurovascular stent market, as are advancements and heightened awareness of microcoil techniques in preventing cerebral aneurysms.






For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds